We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+10.45%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.42B
AUM Growth
-$76.4M
(-5.1%)
Cap. Flow
-$185M
Cap. Flow
% of AUM
-13.05%
Top 10 Holdings %
Top 10 Hldgs %
45.84%
Holding
51
New
8
Increased
9
Reduced
10
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDCO
Medicines Co
MDCO
|
+$49.6M |
| 2 |
ACOR
Acorda Therapeutics
ACOR
|
+$38.1M |
| 3 |
TRLA
TRULIA INC (DEL)
TRLA
|
+$33.1M |
| 4 |
Labcorp
LH
|
+$31M |
| 5 |
ECOM
CHANNELADVISOR CORPORATION
ECOM
|
+$30.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$59.4M |
| 2 |
Merck
MRK
|
+$55.4M |
| 3 |
Eli Lilly
LLY
|
+$47.4M |
| 4 |
Vodafone
VOD
|
+$41.9M |
| 5 |
UnitedHealth
UNH
|
+$36.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.99% |
| 2 | Consumer Discretionary | 25.84% |
| 3 | Financials | 10.66% |
| 4 | Communication Services | 8.04% |
| 5 | Technology | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tesla
TSLA
$1.22T
| $91.2M | 6.42% |
5,700,000
+1,200,000
| +27% | +$16.7M |
|
|
OPLN
2
Openlane
OPLN
$4.2B
| $76.5M | 5.38% |
6,340,800
| – | – |
|
|
3
Labcorp
LH
$25.2B
| $67.3M | 4.74% |
765,330
+357,930
| +88% | +$31M |
|
4
Morgan Stanley
MS
$334B
| $64.7M | 4.55% |
2,000,000
-310,500
| -13% | -$9.57M |
|
5
Charter Communications
CHTR
$17.3B
| $63.4M | 4.46% |
400,000
| – | – |
|
6
TripAdvisor
TRIP
$1.64B
| $62.5M | 4.4% |
575,000
+160,000
| +39% | +$14.7M |
|
7
General Motors
GM
$79.4B
| $61.5M | 4.33% |
1,695,000
| – | – |
|
8
Assured Guaranty
AGO
$3.69B
| $57.6M | 4.05% |
2,350,000
+350,000
| +18% | +$8.68M |
|
|
MDCO
9
DELISTED
Medicines Co
MDCO
| $54M | 3.8% |
+1,858,738
| New | +$49.6M |
|
|
PNK
10
DELISTED
Pinnacle Entertainment Inc.
PNK
| $52.8M | 3.71% |
2,096,481
| – | – |
|
11
Tenet Healthcare
THC
$20.3B
| $49.3M | 3.47% |
1,050,284
+265,284
| +34% | +$12M |
|
|
EVHC
12
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $48.2M | 3.39% |
448,178
+92,468
| +26% | +$9.51M |
|
13
HCA Healthcare
HCA
$86.1B
| $46.8M | 3.29% |
830,000
+85,000
| +11% | +$4.48M |
|
|
TRNX
14
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $46.6M | 3.28% |
1,991,092
| – | – |
|
15
Booking.com
BKNG
$150B
| $45.7M | 3.22% |
950,000
-237,500
| -20% | -$11.4M |
|
|
TRLA
16
DELISTED
TRULIA INC (DEL)
TRLA
| $42.6M | 3% |
+900,000
| New | +$33.1M |
|
|
MNK
17
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $40M | 2.82% |
500,000
-25,000
| -5% | -$1.81M |
|
18
Teva Pharmaceuticals
TEVA
$40.6B
| $39.4M | 2.78% |
752,500
-262,500
| -26% | -$13.4M |
|
19
Meta Platforms (Facebook)
META
$1.39T
| $38.7M | 2.72% |
575,000
-80,000
| -12% | -$4.92M |
|
20
VeriSign
VRSN
$26.1B
| $38.6M | 2.72% |
791,000
-430,000
| -35% | -$21.4M |
|
|
ACOR
21
DELISTED
Acorda Therapeutics
ACOR
| $37.8M | 2.66% |
+9,333
| New | +$38.1M |
|
|
WMGI
22
DELISTED
Wright Medical Group Inc
WMGI
| $36M | 2.53% |
1,145,000
-118,284
| -9% | -$3.53M |
|
|
AGN
23
DELISTED
Allergan Inc
AGN
| $34.7M | 2.44% |
205,000
-140,000
| -41% | -$21.8M |
|
|
ECOM
24
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $31.6M | 2.23% |
+1,200,000
| New | +$30.4M |
|
25
Alnylam Pharmaceuticals
ALNY
$27.3B
| $31.6M | 2.22% |
500,000
+60,000
| +14% | +$3.57M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q2 2014 Portfolio in Review
As of Q2 2014, Bridger Management held 51 positions worth $1.42B, down 5.1% from $1.5B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Bridger Management withdrew a net $185M in Q2 2014, closing 13 positions and reducing 10 holdings. Its most notable exit was Spirit Airlines, Inc., an estimated $59.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 41% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Bridger Management opened a new position in Medicines Co worth $54M.
- Bridger Management's largest Q2 2014 buy was Medicines Co: 1,858,738 shares worth $54M.
- Bridger Management added most to Labcorp in Q2 2014, an estimated $31M increase.
- Bridger Management's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $21.8M.
- Bridger Management fully exited Spirit Airlines, Inc. in Q2 2014, selling an estimated $59.4M.
- Bridger Management's ten largest holdings make up 46% of its $1.42B portfolio in Q2 2014.
- Bridger Management opened 8 new positions and closed 13 in Q2 2014.
- Bridger Management's portfolio value fell 5.1% quarter-over-quarter to $1.42B.
Based on Bridger Management's 13F filing for Q2 2014, filed 14 Aug 2014.